ConductScience.org, home
IVL: involucrin
API referenceFor AI assistants

Gene · 3713

Papers3,772

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 3,772

Download this page as JSON
TitleJournalYearPMIDFound bySource
Pedunculoside alleviates cheilitis-like inflammation by suppressing the TLR3/TRIF/NF-κB signaling.Int Immunopharmacol202642805066PubTator, text miningPubMed
Anoectochilus roxburghii extract alleviates inflammation and restores skin barrier function in vitro and in vivo.Fitoterapia202642800590PubTator, text miningPubMed
ML281 Does Not Function as an STK33 Inhibitor but Modulates Proliferation and Differentiation of Keratinocytes Derived from Hypertrophic Scars.Int J Mol Sci202642794700PubTator, text miningPubMed
Dynamic flow-driven in vitro skin model reveals mechanosensitive remodeling pathways.Hum Cell202642789213PubTator, text miningPubMed
Lipoic acid synthase modulates psoriasis-like keratinocyte dysfunction in association with oxidative stress, ferroptosis-associated remodeling, and STAT3/NF-κB activation.Naunyn Schmiedebergs Arch Pharmacol202642776206PubTator, text miningPubMed
A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy.J Med Chem202642720490PubTator, text miningPubMed
Enzymatically Hydrolyzed Eggshell Membrane Promotes Keratinocyte Differentiation Associated With PKC and Akt Signaling Pathways.J Food Sci202642644214PubTator, text miningPubMed
Direct Effects of 308-nm Excimer Light on Keratinocyte Proliferation and Differentiation in Human Organ-Cultured Skin.Int J Mol Sci202642589355PubTator, text miningPubMed
Repetin Regulates Epidermal Barrier Homeostasis and Is Associated With Inflammatory Skin Diseases.Exp Dermatol202642544840PubTator, text miningPubMed
[Evaluation of the skin barrier repair function and anti-inflammatory activity of recombinant mussel mucin Mfp151].Sheng Wu Gong Cheng Xue Bao202642522623PubTator, text miningPubMed
Multi-omics integration of gut-skin axis in probiotic-treated dermatological conditions.Front Cell Infect Microbiol202642516436PubTator, text miningPubMed
Translational Assessment of a Cell-Penetrating Peptide Topical Formulation for Repairing Barrier Dysfunction in Human Skin.Int J Mol Sci202642511700PubTator, text miningPubMed
Hyssopus officinalis L. (Lamiaceae) Cell Culture Extract Modulates Epidermal Lipid-Related and Differentiation Markers.Cells202642505409PubTator, text miningPubMed
The LCE3D/TGF-β1 Axis in atopic dermatitis: Expression profiling, clinical significance, and mechanistic insights into epithelial-immune crosstalk.Clin Immunol202642435926PubTator, text miningPubMed
High-Level Secretory Expression of Recombinant Type XVII Human-like Collagen in Komagataella phaffii.Int J Mol Sci202642353332PubTator, text miningPubMed
Characterization and development of a gelatin/elastin methacrylamide-based bioink for creating a 3D bioprinted human skin model.Int J Biol Macromol202642264254PubTator, text miningPubMed
Ultrasound-assisted enzymatic extraction of citrus pomace yields dietary fiber-rich extract with skin-protective effects.J Sci Food Agric202642240571PubTator, text miningPubMed
High-level secretory production of a highly hydrophilic human-like type III collagen in Komagataella phaffii by a multicopy genomic integration strategy.Biotechnol Lett202642217068PubTator, text miningPubMed
Targeting Psoroptes ovis MIF to improve skin barrier function: A novel prophylactic strategy for psoroptic mange.Vet Parasitol202642184501PubTator, text miningPubMed
S-PrediXcan predicted gene expression in human placenta is associated with childhood-onset asthma risk.Sci Rep202642129325PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3713/papers

API referenceFor AI assistants